Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin
Open Access
- 1 May 2011
- journal article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 6, 1027-1034
- https://doi.org/10.2147/ijn.s18023
Abstract
Peer reviewed article authored by (Wang J, Chen B, Cheng J, Cai X, Xia G, Liu R, Wang X). Read article or submit your manuscript for publishing.Keywords
This publication has 24 references indexed in Scilit:
- Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticlesInternational Journal of Nanomedicine, 2011
- A biotechnological perspective on the application of iron oxide magnetic colloids modified with polysaccharidesBiotechnology Advances, 2010
- Effect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cellsInternational Journal of Nanomedicine, 2009
- Inhibition of P-glycoprotein-mediated docetaxel efflux sensitizes ovarian cancer cells to concomitant docetaxel and SN-38 exposureAnti-Cancer Drugs, 2009
- Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imagingBiomaterials, 2008
- Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasisJournal of Lipid Research, 2006
- Ligand-targeted therapeutics in anticancer therapyNature Reviews Cancer, 2002
- ApoptosisCell, 2002
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell deathOncogene, 2000